Related Experiment Video
Updated: Nov 10, 2025

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Insight into Functional Membrane Proteins by Solution NMR: The Human Bcl-2 Protein-A Promising Cancer Drug Target
Ameeq Ul Mushtaq1, Jörgen Ådén1, Tobias Sparrman1
1Department of Chemistry, Umeå University, SE-901 87 Umeå, Sweden.
Abstract:
Evasion from programmed cell death (apoptosis) is the main hallmark of cancer and a major cause of resistance to therapy. Many tumors simply ensure survival by over-expressing the cell-protecting (anti-apoptotic) Bcl-2 membrane protein involved in apoptotic regulation. However, the molecular mechanism by which Bcl-2 protein in its mitochondrial outer membrane location protects cells remains elusive due to the absence of structural insight; and current strategies to therapeutically interfere with these Bcl-2 sensitive cancers are limited. Here, we present an NMR-based approach to enable structural insight into Bcl-2 function; an approach also ideal as a fragment-based drug discovery platform for further identification and development of promising molecular Bcl-2 inhibitors. By using solution NMR spectroscopy on fully functional intact human Bcl-2 protein in a membrane-mimicking micellar environment, and constructs with specific functions remaining, we present a strategy for structure determination and specific drug screening of functional subunits of the Bcl-2 protein as targets. Using 19F NMR and a specific fragment library (Bionet) with fluorinated compounds we can successfully identify various binders and validate our strategy in the hunt for novel Bcl-2 selective cancer drug strategies to treat currently incurable Bcl-2 sensitive tumors.
Insights
Cancer cells evade programmed cell death (apoptosis) by over-expressing the anti-apoptotic Bcl-2 protein. This study uses NMR to reveal Bcl-2
Area of Science:
- Biochemistry
- Structural Biology
- Cancer Biology
Background:
- Evasion of apoptosis is a key hallmark of cancer, often driven by overexpression of anti-apoptotic proteins like Bcl-2.
- The precise molecular mechanisms of Bcl-2's protective function at the mitochondrial outer membrane are not fully understood due to a lack of structural data.
- Current therapeutic strategies targeting Bcl-2-sensitive cancers are limited.
Purpose of the Study:
- To elucidate the structural mechanisms underlying Bcl-2's anti-apoptotic function.
- To establish an NMR-based platform for fragment-based drug discovery of Bcl-2 inhibitors.
- To identify novel therapeutic strategies for Bcl-2-sensitive cancers.
Main Methods:
- Solution Nuclear Magnetic Resonance (NMR) spectroscopy was employed on intact human Bcl-2 protein in a membrane-mimicking micellar environment.
- Functional Bcl-2 constructs were utilized for structure determination and drug screening.
- Fluorine-19 (19F) NMR was combined with a fluorinated fragment library (Bionet) for inhibitor screening.
Main Results:
- The study successfully determined structural insights into Bcl-2 function using NMR.
- The NMR approach served as an effective platform for fragment-based drug discovery.
- Specific Bcl-2 binders were identified using 19F NMR and the Bionet library, validating the strategy.
Conclusions:
- The developed NMR strategy provides crucial structural insights into Bcl-2 function.
- This approach enables the screening of functional Bcl-2 subunits as drug targets.
- The findings pave the way for developing novel Bcl-2-selective cancer therapeutics for currently untreatable tumors.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Mitogens and the Cell Cycle
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...